Smoking cessation in advanced-stage cancer patients can extend life by about one year, highlighting its importance in cancer ...

Research is underway for an experimental treatment for patients with succinate dehydrogenase (SDH) deficient gastrointestinal ...

Baker, who is based in the United Kingdom, recently sat down for an interview with CURE alongside Dr. Marina Kremyanskaya, ...

Bernadette, a stage 4 cancer patient, inspires others with her faith and optimism, becoming a mentor within her support group. She participates in a promising drug trial using T cell therapy to ...

Stage 1 PV management includes phlebotomy, low-dose aspirin, cytoreductive therapy, and lifestyle changes to prevent complications. Stage 1 polycythemia vera is manageable with monitoring, phlebotomy, ...

Immunotherapies, such as the blockbuster immune checkpoint inhibitor drug Keytruda (pembrolizumab), work by keeping cancer cells from suppressing a patient’s immune system and thus allowing the immune ...

Surviving breast cancer heightens awareness of bodily changes, with new symptoms potentially triggering fears of recurrence.

Dr. Charles M. Rudin highlighted new small cell lung cancer therapies, including T cell engagers, antibody-drug conjugates, ...

The phase 2 SANRECO study has recently completed enrollment and will evaluate divesiran, a potential therapy for patients ...

Voranigo (vorasidenib), a drug for certain brain tumors, was safe and well toleratedin patients with grade 3 or 4 IDH-mutant ...

In observation of Neuroendocrine Tumors (NETs) Awareness Month, Dr. Pamela L. Kunz sat down for an interview with CURE to ...

Sac-TMT combined with Keytruda significantly improves progression-free survival in PD-L1-positive advanced non-small cell ...